| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/31/2008 | US20080025993 Method for Refolding Neisserial Nspa Protein |
| 01/31/2008 | US20080025983 Methods of screening based on the EGF receptor crystal structure |
| 01/31/2008 | US20080025978 High affinity ligand for p75 neurotrophin receptor |
| 01/31/2008 | US20080025974 Toll-like receptor polypeptides for generating atibodies for use in treatment and prevention of septic shock, inflammation and viral infection |
| 01/31/2008 | US20080025957 Stem Cells Suitable for Transplantation, their Preparation and Pharmaceutical Compositions Comprising Them |
| 01/31/2008 | US20080025951 Administering to an individual having acute liver disease or inflammatory skin disease a carrier and a specific polypeptide that contains signal peptide sequences and a transmembrane spanning domain |
| 01/31/2008 | US20080025950 Modified Macromolescules and Associated Methods of Synthesis and Use |
| 01/31/2008 | US20080025947 Methods for enhancing the efficacy of IL-2 mediated immune responses |
| 01/31/2008 | US20080025914 Bi-specific monoclonal antibody (specific for both CD3 and CD11b) therapeutic drug |
| 01/31/2008 | US20080023859 Glycopeptides and Temperature-Responsive Micelles |
| 01/31/2008 | DE102006052915A1 Composition, useful in pharmaceutical products to treat diarrhea and as dietary products to promote intestinal health, comprises polyphenol and milk-peptide |
| 01/31/2008 | DE102006034319A1 Chirale mit Phosponsäurester- oder Phosphonsäure- substituierte Verbindungen Chiral with Phosponsäurester- or phosphonic acid substituted compounds |
| 01/31/2008 | CA2659262A1 Improved vaccines and methods for using the same |
| 01/31/2008 | CA2659225A1 Immunogenic compounds and protein mimics |
| 01/31/2008 | CA2658824A1 Compositions and methods for diagnosing patients with acute atherosclerotic syndromes |
| 01/31/2008 | CA2658806A1 Cytokine derivatives |
| 01/31/2008 | CA2658786A1 Methods of inhibiting tumor cell aggressiveness using the microenvironment of human embryonic stem cells |
| 01/31/2008 | CA2658713A1 Recombinant mycobacterium strain expressing a mycobacterial fap protein under the control of a promoter active under hypoxia and its application for cancer therapy |
| 01/31/2008 | CA2658654A1 Exendin fusion proteins |
| 01/31/2008 | CA2658563A1 Crohn disease susceptibility gene |
| 01/31/2008 | CA2657563A1 Post-translationally modified neurotrophins |
| 01/31/2008 | CA2657238A1 Compositions and methods for treating or preventing ophthalmic disease |
| 01/31/2008 | CA2657164A1 Compositions and methods for treating or preventing ophthalmic light toxicity |
| 01/31/2008 | CA2657135A1 High-cell density fed-batch fermentation process for producing recombinant protein |
| 01/31/2008 | CA2657015A1 Opsin stabilizing compounds and methods of use |
| 01/31/2008 | CA2619983A1 Fully human hybridoma fusion partner cell lines |
| 01/30/2008 | EP1882744A1 Method for producing an interleukin-2 preparation and the thus obtainable preparation |
| 01/30/2008 | EP1882743A1 Method for producing protein |
| 01/30/2008 | EP1882741A1 Recombinant Mycobacterium strain expressing a mycobacterial FAP protein under the control of a promoter active under hypoxia and its application for cancer therapy |
| 01/30/2008 | EP1882700A1 Biotinylated MHC complexes and their uses |
| 01/30/2008 | EP1882699A1 Regulation of interleukin-23 |
| 01/30/2008 | EP1882698A1 Design of interferon-inducible protein-10 (IP10 or CXCL10) chemokine analogs for the treatment of human diseases |
| 01/30/2008 | EP1882697A1 Post-translationally modified neurotrophins |
| 01/30/2008 | EP1882696A2 PRRSV antigenic sites identifying peptide sequences of PRRS virus for use in vaccines or diagnostic assays |
| 01/30/2008 | EP1882688A1 Labelling of fusion proteins with synthetic probes |
| 01/30/2008 | EP1882478A1 Fusion protein of porcine reproductive and respiratory syndrome virus as PRRS vaccine |
| 01/30/2008 | EP1882047A2 Compositions, methods and kits for real-time nucleic acid analysis in live cells |
| 01/30/2008 | EP1882038A2 Corn plants and seed enhanced for asparagine and protein |
| 01/30/2008 | EP1882035A2 Genes and proteins of brachyspira hyodysenteriae and use of same for diagnosis and therapy |
| 01/30/2008 | EP1881992A2 Isolated aqdecay photoprotein and use thereof |
| 01/30/2008 | EP1881962A2 Thiosuccinic acid derivatives and the use thereof |
| 01/30/2008 | EP1881850A1 Glp-1 pegylated compounds |
| 01/30/2008 | EP1163254B1 Trpm-2 antisense therapy |
| 01/30/2008 | EP0972063B1 Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereof |
| 01/30/2008 | EP0737249B1 Tumor suppressor protein prb2, related gene products, and dna encoding therefor |
| 01/30/2008 | CN101115995A Covalent tethering of functional groups to proteins and substrates therefor |
| 01/30/2008 | CN101115839A Method for inhibiting fibrogenesis by an rhdecorin-fc fusion protein |
| 01/30/2008 | CN101115771A 人类抗体和蛋白质 Human antibodies and proteins |
| 01/30/2008 | CN101115770A Pyy agonists and uses thereof |
| 01/30/2008 | CN101115769A Interferon-alpha polypeptides and conjugates |
| 01/30/2008 | CN101115768A Novel hydrophobin fusion products, production and use thereof |
| 01/30/2008 | CN101115767A vWFA and/or ANTúIG domain containing proteins |
| 01/30/2008 | CN101115766A Codon-optimized HPV16LI for salmonella vaccine strains against human papillomavirus type 16 |
| 01/30/2008 | CN101115500A Compositions for immunizing against mycobacterium |
| 01/30/2008 | CN101113451A Black nightshade pest-resistant gene and uses thereof |
| 01/30/2008 | CN101113450A Neurotrophic factor |
| 01/30/2008 | CN101113449A Neurotrophic factor |
| 01/30/2008 | CN101113448A Agkistrodon halys ussuriensis disintegrin site-directed mutants cDNA clone, expression and protein preparation method and application thereof |
| 01/30/2008 | CN101113424A Coleoptera pest efficient Bacillus thuringiensis cry8G gene, protein and uses thereof |
| 01/30/2008 | CN101113178A Novel immunogenic lipopeptides comprising t-helper and cytotoxic t lymphocyte (CTL) epitopes |
| 01/30/2008 | CN101113175A Rat-rabbit family thin element protein and its cDNA sequence |
| 01/30/2008 | CN101113174A Method for separating isomerism protein from recombinant human ciliary neurotrophy factor and its mutant |
| 01/30/2008 | CN101113173A Synthetic antimicrobial polypeptides |
| 01/30/2008 | CN101113172A Anti-opium peptide and antagonistic peptide and its application |
| 01/30/2008 | CN101113171A Peptide for increasing animal food ingestion |
| 01/30/2008 | CN101113170A Preparation of new gene cell cycle related tumour high-expression gene monoclonal antibody and its application |
| 01/30/2008 | CN101113169A Use of sorting protein SNX10 for suppressing growth of tumour cell |
| 01/30/2008 | CN101113168A Peanut protein active polypeptide and method for making same |
| 01/30/2008 | CN101113167A Recombinant main outer membrane protein of chlamydi trachomatis and preparation method and application thereof |
| 01/30/2008 | CN101113166A Recombinant main outer membrane protein of Chlamydophila pneumoniae and preparation method thereof |
| 01/30/2008 | CN101113165A SEC2 super antigen gene engineering peptide and encoding gene and heterogenous expression method thereof |
| 01/30/2008 | CN101113163A Hla-a24-restricted cancer antigen peptides |
| 01/30/2008 | CN101113162A Method for extracting centipede acidic protein and application of centipede acidic protein extracted by the method in preparation of medicine for treating heart disease |
| 01/30/2008 | CN100365125C Novel cell wall anchor proteins derived from yeast, genes thereof and cell surface expression systems using the same |
| 01/30/2008 | CN100365120C Compounds and methods for treatment and diagnosis of chlamydial infection |
| 01/30/2008 | CN100365117C Pegylated and diglycosylated erythropoietin |
| 01/30/2008 | CN100365114C Gram negative coccoid bacterium |
| 01/30/2008 | CN100365021C Nucleic protein 'Shoca'-a component of wnt signal transmission channel |
| 01/30/2008 | CN100365020C Protein from snake venom for preventing and treating pyemia |
| 01/30/2008 | CN100365019C Purple laver protein and polysaccharide product, and method of ultrasonic assistant extraction |
| 01/30/2008 | CN100365018C Antibiotic peptides and their prepn process and application |
| 01/30/2008 | CN100365017C Antigenic polypeptide of chlamydia pneumoniae |
| 01/30/2008 | CN100364611C Peptide immunotherapeutic agent |
| 01/30/2008 | CN100364609C Prekallikrein depleted plasma derived albumin fraction |
| 01/30/2008 | CN100364606C Peptide compositions and formulations and use of same |
| 01/29/2008 | US7324846 Method of enchancing electrontransport polypeptide flux by amino acid substitution with histidine |
| 01/29/2008 | US7323623 Molecules encoding defensive polypeptides; enhancing disease resistance of a plant to a fungal pathogen; vectors, expression cassettes, viruses, cells, and plants |
| 01/29/2008 | US7323560 Plastidic phosphoglucomutase genes |
| 01/29/2008 | US7323559 Genes encoding genetic stability, gene expression and folding proteins |
| 01/29/2008 | US7323557 Genome of the HIV-1 inter-subtype (C/B') and use thereof |
| 01/29/2008 | US7323552 Genetic engineering; diagnosis of antiinflammatory agents |
| 01/29/2008 | US7323550 Anti-PRO4318 antibodies |
| 01/29/2008 | US7323549 IL-7 fusion proteins |
| 01/29/2008 | US7323548 Antibodies or active fragments specific for MORT-1 (Mediator of Receptor Toxicity) protein having amino acid sequence 2; tumors, hiv |
| 01/29/2008 | US7323547 Highly expressed peptide of white spot syndrome virus in hosts and application thereof |
| 01/29/2008 | US7323546 Apoptosis-inducing polypeptides |
| 01/29/2008 | US7323545 PRO1885 polypeptides |
| 01/29/2008 | US7323544 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders |
| 01/29/2008 | US7323543 Insulin, insulin-related peptide, and sensitizer; side effect reduction |
| 01/29/2008 | US7323541 Polypeptide DNA thereof and use of the same |